DK164684A - 4-substituerede-2-azetidinon-forbindelser, fremgangsmaade til fremstilling heraf og mellemprodukter til brug herved - Google Patents

4-substituerede-2-azetidinon-forbindelser, fremgangsmaade til fremstilling heraf og mellemprodukter til brug herved Download PDF

Info

Publication number
DK164684A
DK164684A DK164684A DK164684A DK164684A DK 164684 A DK164684 A DK 164684A DK 164684 A DK164684 A DK 164684A DK 164684 A DK164684 A DK 164684A DK 164684 A DK164684 A DK 164684A
Authority
DK
Denmark
Prior art keywords
slaughter
stalling
pigs
stalling pigs
Prior art date
Application number
DK164684A
Other languages
Danish (da)
English (en)
Other versions
DK164684D0 (da
Inventor
Toshinari Tamura
Hidenori Iwamoto
Makoto Yoshida
Minoru Yamamoto
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP58048989A external-priority patent/JPS59225182A/ja
Priority claimed from JP58221469A external-priority patent/JPS60115577A/ja
Priority claimed from JP58221470A external-priority patent/JPS60115578A/ja
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of DK164684D0 publication Critical patent/DK164684D0/da
Publication of DK164684A publication Critical patent/DK164684A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06147—Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK164684A 1983-03-25 1984-03-23 4-substituerede-2-azetidinon-forbindelser, fremgangsmaade til fremstilling heraf og mellemprodukter til brug herved DK164684A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP58048989A JPS59225182A (ja) 1983-03-25 1983-03-25 ２−アゼチジノン−４−カルボン酸の誘導体
JP58221469A JPS60115577A (ja) 1983-11-25 1983-11-25 ２−アゼチジノン−４−置換体
JP58221470A JPS60115578A (ja) 1983-11-25 1983-11-25 ２−アゼチジノン−４−置換化合物

Publications (2)

Publication Number Publication Date
DK164684D0 DK164684D0 (da) 1984-03-23
DK164684A true DK164684A (da) 1984-09-26

Family

ID=27293483

Family Applications (1)

Application Number Title Priority Date Filing Date
DK164684A DK164684A (da) 1983-03-25 1984-03-23 4-substituerede-2-azetidinon-forbindelser, fremgangsmaade til fremstilling heraf og mellemprodukter til brug herved

Country Status (8)

Country Link
US (3) US4564609A (de)
EP (1) EP0123444B1 (de)
KR (3) KR870000357B1 (de)
CA (1) CA1256650A (de)
DE (1) DE3476399D1 (de)
DK (1) DK164684A (de)
ES (4) ES530960A0 (de)
NO (1) NO158740C (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719207A (en) * 1984-06-25 1988-01-12 Yamanouchi Pharmaceutical Co., Ltd. CNS active substituted azetidinone compounds
JPS6253994A (ja) 1985-05-09 1987-03-09 Yamanouchi Pharmaceut Co Ltd １−置換シリル−４−オキソ−２−アゼチジンカルボン酸低級アルキルエステル
ZA868957B (en) * 1985-12-06 1987-07-29 Yamanouchi Pharma Co Ltd Crystals of nalpha-(((s)-4-oxo-2-azetidinyl)carbonyl)-l-histidyl-l-prolinamide and process for producing the crystals
US5686420A (en) * 1987-06-05 1997-11-11 Georgetown University Thyrotropin-releasing hormone analogs and method of use
US5151497A (en) * 1989-02-21 1992-09-29 Japan Tobacco Inc. Histidyl peptide derivatives
DK437289D0 (da) * 1989-09-04 1989-09-04 Hans Bundgaard Prodrug derivatives of thyrotropin-releasing hormone (trh)
IT1249728B (it) * 1991-11-06 1995-03-09 Sigma Tau Ind Farmaceuti Derivati delle prolinammide quali attivatori della memoria e dei processi di apprendimento e composizioni farmaceutiche che li contengono
JP2001524132A (ja) * 1997-05-09 2001-11-27 スミスクライン・ビーチャム・コーポレイション ＣｏＡ−ＩＴのベータ−ラクタム阻害剤
US20020151502A1 (en) * 1997-10-09 2002-10-17 Albert Sattin Tri-peptides for neurological and neurobehavior applications
US7202279B1 (en) * 1998-02-11 2007-04-10 Georgetown University Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
US20030175350A1 (en) * 2000-07-11 2003-09-18 Katsuji Sugita Enteric preparations containing physiologically active peptides
JP4817281B2 (ja) 2000-08-31 2011-11-16 塩野義製薬株式会社 パーキンソン病治療剤
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
JP4777602B2 (ja) * 2001-01-26 2011-09-21 シェーリング コーポレイション ペルオキシソーム増殖因子活性化レセプター（ｐｐａｒ）活性化剤およびステロール吸収阻害剤の組合せおよび血管症状の処置
PL369033A1 (en) * 2001-01-26 2005-04-18 Schering Corporation Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
US20020183305A1 (en) * 2001-01-26 2002-12-05 Schering Corporation Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
PL205343B1 (pl) * 2001-01-26 2010-04-30 Schering Corp Zastosowanie inhibitora wchłaniania sterolu
WO2002058733A2 (en) * 2001-01-26 2002-08-01 Schering Corporation Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
DE60224163T2 (de) * 2001-01-26 2008-12-04 Schering Corp. Kombinationen von ezetimibe und aspirin zur behandlung von kardiovaskulären erkrankungen
PT1392287E (pt) * 2001-05-25 2007-02-28 Schering Corp Métodos para tratamento de doença de alzheimer e/ou regulação dos níveis de peptídeos β amilóide num sujeito
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
AU2002336609B2 (en) * 2001-09-21 2006-08-24 Merck Sharp & Dohme Corp. Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
DE60229406D1 (de) * 2001-09-21 2008-11-27 Schering Corp Verfahren zur behandlung oder verhinderung von vaskulärer entzündung mit sterol-absorbierungs- inhibitor(en)
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
WO2004043456A1 (en) * 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorption inhibitors for the treatment of demyelination
CA2517573C (en) * 2003-03-07 2011-12-06 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
MXPA05009501A (es) * 2003-03-07 2005-10-18 Schering Corp Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
US7459442B2 (en) * 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
JP5137228B2 (ja) * 2003-03-07 2013-02-06 メルク・シャープ・アンド・ドーム・コーポレーション 高コレステロール血症の処置のための置換アゼチジノン化合物、置換アゼチジノン処方物およびそれらの使用
WO2005046797A2 (en) * 2003-11-05 2005-05-26 Schering Corporation Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
US7462595B2 (en) * 2004-09-17 2008-12-09 Prange Jr Arthur Jergen Methods for treating cancer-related fatigue
KR101137503B1 (ko) * 2009-07-14 2012-04-20 웰이앤씨 주식회사 고분자 고체 지지체를 이용한 히스티딜-프롤린아미드 유도체의 제조 방법
MA38833B2 (fr) 2013-08-16 2019-04-30 Los Alamos National Security Llc Composés et procédés pour améliorer des performances d'une plante

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959248A (en) * 1974-04-03 1976-05-25 Merck & Co., Inc. Analogs of thyrotropin-releasing hormone
GB1523598A (en) * 1975-03-08 1978-09-06 Reckitt & Colmann Prod Ltd Tripeptides
US4271164A (en) * 1979-04-16 1981-06-02 Warner-Lambert Company 6-Substituted-arylpyrido[2,3-d]pyrimidin-7-amines and derivatives
HU180926B (en) * 1979-06-28 1983-05-30 Richter Gedeon Vegyeszet Process for preparing trh analogues,tripeptide amides infectives on the central nerve sysrhem
US4328134A (en) * 1980-05-06 1982-05-04 Schally Andrew Victor Anorexigenic peptides
US4426378A (en) * 1981-04-09 1984-01-17 The United States Of America As Represented By The Secretary Of The Army Thyrotropin releasing hormone in therapy of shock and as a central nervous system stimulant

Also Published As

Publication number Publication date
KR880009550A (ko) 1988-09-15
CA1256650A (en) 1989-06-27
US4636567A (en) 1987-01-13
ES8604209A1 (es) 1986-01-16
KR840008021A (ko) 1984-12-12
ES8600279A1 (es) 1985-10-01
EP0123444B1 (de) 1989-01-25
NO158740C (no) 1988-10-26
KR890002105B1 (ko) 1989-06-19
US4564609A (en) 1986-01-14
DK164684D0 (da) 1984-03-23
US4610821A (en) 1986-09-09
ES544236A0 (es) 1986-01-16
KR870000357B1 (ko) 1987-03-05
KR890002104B1 (ko) 1989-06-19
KR880009549A (ko) 1988-09-15
ES544234A0 (es) 1986-01-16
NO841158L (no) 1984-09-26
ES8604136A1 (es) 1986-01-16
EP0123444A1 (de) 1984-10-31
ES8604208A1 (es) 1986-01-16
ES544235A0 (es) 1986-01-16
NO158740B (no) 1988-07-18
DE3476399D1 (en) 1989-03-02
ES530960A0 (es) 1985-10-01

Similar Documents

Publication Publication Date Title
DK164684A (da) 4-substituerede-2-azetidinon-forbindelser, fremgangsmaade til fremstilling heraf og mellemprodukter til brug herved
GB2138926B (en) Muzzle reference system
GB8418272D0 (en) Wear-parts system
GB8422613D0 (en) Conveyor system
DE3480054D1 (en) Pump-actuated sequencing system
GB2143667B (en) Instruction system topic-interpreting method
GB8304384D0 (en) Photobleach system
GB8402153D0 (en) Conveyor system
GB2137718B (en) Flow-stopping system
GB2169809B (en) Combined insufflation-irrigation system for an endoscope
GB8406613D0 (en) Magnetic-electronic system
GB2140366B (en) Side-support system for crawler-driven units
ZA852292B (en) Apparatus for decapitating fish
GB2152004B (en) Conveyor system
GB2143886A (en) Formwok system
GB8314968D0 (en) Apparatus for slaughtering animals
GB8423721D0 (en) Anti-icing system
GB8315232D0 (en) Conveyor system
IE820194L (en) Rearing unit for pigs
GB2140647B (en) 3d-television system
DE3563298D1 (en) Storage system for carcasses
GB2140761B (en) Conveyor system
PL236859A1 (en) Swine slaughtering method
GB8329609D0 (en) Cattle flooring system
ZA84608B (en) Processor system

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment